iPath Inverse S&P 500 VIX Short-Term Futures
IVOP
IVOP was delisted on the 23rd of March, 2018.
3 hedge funds and large institutions have $436K invested in iPath Inverse S&P 500 VIX Short-Term Futures in 2016 Q1 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
3% less capital invested
Capital invested by funds: $450K → $436K (-$14K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$8.72K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.67K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $403K | -$6.67K | -176 | -2% |
|
|
2
UBS Group
Zurich,
Switzerland
| $33K | -$8.72K | -230 | -21% |
|
IVOP Hedge Fund Activity: Q1 2016 in Review
3 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in iPath Inverse S&P 500 VIX Short-Term Futures (IVOP) for Q1 2016, worth a combined $436K — down 3.1% from $450K a quarter earlier.
Fund positioning in IVOP was balanced in Q1 2016: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was UBS Group, cutting an estimated $8.72K.
- 3 institutional investors held iPath Inverse S&P 500 VIX Short-Term Futures (IVOP) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $436K of iPath Inverse S&P 500 VIX Short-Term Futures stock for Q1 2016, down 3.1% quarter-over-quarter.
- 0 funds opened new iPath Inverse S&P 500 VIX Short-Term Futures positions in Q1 2016 and 0 closed out.
- The largest iPath Inverse S&P 500 VIX Short-Term Futures seller in Q1 2016 was UBS Group, an estimated $8.72K sold.
Based on aggregated 13F filings for Q1 2016.